NRx Pharmaceuticals Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD

0.06

-0.00 (-0.17%)

At close: Apr 29, 2025, 11:40 AM

NRx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-25.13M	-30.15M	-39.75M	-93.06M	-51.78M	408.43K	66.1K	-105.03K
Depreciation & Amortization	5K	5K	4K	2K	2K	0.86	n/a	n/a
Stock-Based Compensation	486K	387K	3.63M	7.79M	730K	933.90	n/a	n/a
Other Working Capital	10.51M	2.51M	2.31M	-5.71M	3.1M	-66.68K	84.2K	-87K
Other Non-Cash Items	8.71M	2.94M	-4.33M	54.28M	39.61M	-1.28M	-1.55M	-115.11K
Deferred Income Tax	n/a	n/a	n/a	-1.81M	5.72M	70.41K	n/a	n/a
Change in Working Capital	5.29M	5.16M	699K	-4.9M	3.45M	4.66K	549.63K	-1.33K
Operating Cash Flow	-10.64M	-21.66M	-39.76M	-37.7M	-2.27M	-792.73K	-473.19K	-135.81K
Capital Expenditures	n/a	-3K	-10K	-7K	-2K	-3.55	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-10K	-7K	n/a	-993.1K	-690K	-69M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	41.24M	42.39K	n/a
Other Investing Acitivies	n/a	n/a	10K	7K	26.18M	3.55	-647.61K	-69M
Investing Cash Flow	n/a	-3K	-10K	-7K	-2K	40.25M	-647.61K	-69M
Debt Repayment	-1.5M	-3.09M	9.5M	n/a	620K	n/a	690K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-40.73M	n/a	70.03M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.07M	n/a	22.71M	26.47M	n/a	1.26M	n/a	n/a
Financial Cash Flow	7.49M	6.2M	32.21M	63.46M	3.25M	-39.46M	682.5K	69.59M
Net Cash Flow	-3.15M	-15.46M	-7.55M	25.75M	982K	-11.07K	-438.3K	449.37K
Free Cash Flow	-10.64M	-21.66M	-39.77M	-37.71M	-2.27M	-792.73K	-473.19K	-135.81K